Jim Appleman, Ph.D. Email & Phone Number

Highly qualified R&D executive with over twenty years of professional experience and demonstrated strengths in:• Corporate governance• Strategic R&D planning• Management of corporate and academic alliances• Portfolio management and cross-project coordination• Departmental and staff management• Project leadership and management - Drug Discovery - Translational Medicine - Clinical Research• Information Technologies and Scientific Computing managementProviding consulting services to the pharmaceutical and biotech industries focusing on target discovery through phase II (proof of concept) clinical studies with particular emphasis on:• Translational biology• Preclinical pharmacology and ADME/DMPK• Informational sciences (IT, bioinformatics, cheminformatics)• Portfolio and project analysis, leadership and management• Regulatory document preparationExemplary accomplishments• Co-founder, Primmune Therapeutics / Evince Biosciences and Effector Therapeutics• Scientific lead, M&A process resulting in sale of Anadys Pharmaceuticals to Roche• Discovery and development of novel oral TLR7 agonist ANA773 for treatment of hepatic viral diseases and cancer• Successful drug discovery organization building

Listed skills include Information Technology, Drug Design, Chemistry, Cheminformatics, and 24 others.